Viveras Pharmaceuticals, the company that makes the insulin injector, wants to increase sales of the injectors and to attract customers with its “super-thin” packaging.The company is looking to increase its share price by around 10% this year as it looks to get into the diabetes market.It is planning to open a new US headquarters in […]

Continue Reading...